Tyrus Capital S.A.M.’s Kite Pharma, Inc. KITE Stock Holding History

Tyrus Capital S.A.M.’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,314,812	Closed	-$236M	–	34
2017 Q3	$236M	Buy	+1,314,812	New	+$183M	18.49%	2

Tyrus Capital S.A.M.'s KITE Position: Q4 2017 in Review

Tyrus Capital S.A.M. sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,314,812 shares — an estimated $236M sold.

Tyrus Capital S.A.M. first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $236M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Tyrus Capital S.A.M. reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Tyrus Capital S.A.M. sold 1,314,812 Kite Pharma, Inc. shares in Q4 2017, an estimated $236M.
Tyrus Capital S.A.M. first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Tyrus Capital S.A.M.'s Kite Pharma, Inc. position peaked at $236M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Tyrus Capital S.A.M.'s 13F filing for Q4 2017, filed 14 Feb 2018.